PDBi (Protein Data Bank in India)

All in One Protein Databank
Home About Help Resources External Links Contact Us
Advanced Search
FASTA Sequence PDB Format mmCIF Format
FASTA Sequence PDB Format PDB Format(gz) PDBx/mmCIF Format PDBx/mmCIF Format(gz) PDBML/XML Format Validation Full PDF Validation CIF

7X8X

Structural insights into mycobacterium tuberculosis clpp1p2 inhibition by cediranib: implications for developing antimicrobial agents targeting clp protease

PDB DOI: 10.2210/pdb7x8x/pdb

Classification: HYDROLASE/HYDROLASE INHIBITOR
Organism(s): Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct

Deposited: 2022-03-15
Deposition Author(s): Bao, R. , Luo, Y.F. , Yang, Y. , Zhou, Y.Z. , Zhu, Y.B.

Experimental Data Snapshot

Method: X-RAY DIFFRACTION
Resolution: 3.24 Å

7x8x
Literature

Structural insights into mycobacterium tuberculosis clpp1p2 inhibition by cediranib: implications for developing antimicrobial agents targeting clp protease

Bao, R. , Luo, Y.F. , Yang, Y. , Zhou, Y.Z. , Zhu, Y.B.

Primary Citation of Related Structures: 7X8X


Proteins
Molecule Chains Sequence Length Organism Sequence
ATP-dependent Clp protease proteolytic subunit 2 A 197 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct YILPSFIEHSSFGVKESNPYNKLFEERIIFLGVQVDDASANDIMAQLLVLESLDPDRDITMYINSPGGGFTSLMAIYDTMQYVRADIQTVCLGQAASAAAVLLAAGTPGKRMALPNARVLIHQPSLSGVIQGQFSDLEIQAAEIERMRTLMETTLARHTGKDAGVIRKDTDRDKILTAEEAKDYGIIDTVLEYRKLS
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide O 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide C 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide Q 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide F 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide S 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide H 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide T 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide J 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide V 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide L 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide X 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide E 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
ATP-dependent Clp protease proteolytic subunit 1 B 177 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct LTDSVYERLLSERIIFLGSEVNDEIANRLCAQILLLAAEDASKDISLYINSPGGSISAGMAIYDTMVLAPCDIATYAMGMAASMGEFLLAAGTKGKRYALPHARILMHQPLGGVTGSAADIAIQAEQFAVIKKEMFRLNAEFTGQPIERIEADSDRDRWFTAAEALEYGFVDHIITR
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide P 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
ATP-dependent Clp protease proteolytic subunit 1 D 177 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct LTDSVYERLLSERIIFLGSEVNDEIANRLCAQILLLAAEDASKDISLYINSPGGSISAGMAIYDTMVLAPCDIATYAMGMAASMGEFLLAAGTKGKRYALPHARILMHQPLGGVTGSAADIAIQAEQFAVIKKEMFRLNAEFTGQPIERIEADSDRDRWFTAAEALEYGFVDHIITR
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide R 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide I 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide U 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide K 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide W 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide M 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide Y 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide N 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide Z 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide G 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide 0 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide 1 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide 2 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide 3 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide 4 3 Mycobacterium Tuberculosis , Mycobacterium Tuberculosis Cdc1551 , Synthetic Construct XLL
Experimental Data

Method: X-RAY DIFFRACTION

Deposited Date: 2022-03-15
Deposition Author(s): Bao, R. , Luo, Y.F. , Yang, Y. , Zhou, Y.Z. , Zhu, Y.B.